Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.19 USD
Change Today -0.0055 / -2.76%
Volume 97.7K
NSPR On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

inspiremd inc (NSPR) Snapshot

Open
$0.20
Previous Close
$0.20
Day High
$0.21
Day Low
$0.19
52 Week High
08/29/14 - $2.48
52 Week Low
08/26/15 - $0.18
Market Cap
15.1M
Average Volume 10 Days
334.6K
EPS TTM
$-0.47
Shares Outstanding
77.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INSPIREMD INC (NSPR)

Related News

No related news articles were found.

inspiremd inc (NSPR) Related Businessweek News

No Related Businessweek News Found

inspiremd inc (NSPR) Details

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard and MGuard prime embolic protection stents for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing PVGuard for use in peripheral vascular applications. It operates in the Middle East, Germany, Belarus, Spain, the Russian Federation, and internationally. The company is headquartered in Boston, Massachusetts.

55 Employees
Last Reported Date: 03/12/15

inspiremd inc (NSPR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $519.1K
Chief Financial Officer, Chief Administrative...
Total Annual Compensation: $236.9K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $194.7K
Chief Technology Officer, Chief Technical Off...
Total Annual Compensation: $201.7K
Compensation as of Fiscal Year 2014.

inspiremd inc (NSPR) Key Developments

InspireMD Announces Distribution Partnership of Its Cguard™ Embolic Prevention System with Penumbra, Inc

InspireMD, Inc. announced that it has entered into a partnership with Penumbra, Inc. to distribute its carotid CGuard EPS through their direct commercialization team. Penumbra is a leading interventional technology company that develops and markets innovative medical devices to the neurovascular and peripheral vascular communities around the world. InspireMD has aggressively been pursuing a strategy in treating carotid artery disease and other neurovascular applications for its proprietary MicroNet™technology. Clinical trials of the CGuard™ system, including the recent CARENET and PARADIGM studies, have continued to support the benefits of the MicroNet™ enhanced CGuard™ system resulting in increased commercial adoption throughout the European market. Penumbra has a direct and distributor sales organization in all markets where the CGuard™ system is commercially available. Penumbra's neurovascular product portfolio includes medical devices for ischemic stroke and brain aneurysms, as well as peripheral vascular products that include products for embolization and thrombectomy. Penumbra has approximately 1,000 global employees with direct sales operations in North America, Europe, and Australia. Penumbra sells through distributors in Asia and select other international markets.

InspireMD, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

InspireMD, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company’s revenue increased $0.5 million to $0.7 million compared to $0.2 million during the same period in 2014. The loss from operations was $3.6 million, a decrease of 50.6% compared to a loss of $7.2 million for the same period in 2014. Net loss totaled $3.9 million, or $0.05 per basic and diluted share, compared to a net loss of $7.6 million, or $0.22 per basic and diluted share, in the same period in 2014. Non-GAAP net loss was $2.9 million, or $0.04 per basic and diluted share, a decrease of 55.6% compared to a non-GAAP net loss of $6.5 million, or $0.19 per basic and diluted share, for the same period in 2014. Loss before tax expenses was $3,895,000 compared to $7,560,000 a year ago. For the six months, the company’s revenue decreased $0.5 million to $1.2 million compared to $1.7 million during the same period in 2014. The loss from operations was $8.5 million, a decrease of 33.7% compared to a loss of $12.8 million for the same period in 2014. Net loss totaled $9.1 million, or $0.14 per basic and diluted share, compared to a net loss of $13.5 million, or $0.40 per basic and diluted share, in the same period in 2014. Non-GAAP net loss was $6.7 million, or $0.11 per basic and diluted share, a decrease of 41.3% compared to a non-GAAP net loss of $11.4 million, or $0.34 per basic and diluted share, for the same period in 2014. Loss before tax expenses was $9,091,000 compared to $13,508,000 a year ago.

InspireMD, Inc. Proposes Amendments to its Amended and Restated Certificate of Incorporation

InspireMD, Inc. at its annual meeting of stockholders to be held on September 9, 2015, proposed amend the amended and restated certificate of incorporation of the company to effect a reverse stock split of common stock at a ratio of one-for-ten and reduce the number of authorized shares of common stock from 125,000,000 to 50,000,000.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NSPR:US $0.19 USD -0.0055

NSPR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $46.02 USD +0.38
Boston Scientific Corp $17.07 USD +0.13
Johnson & Johnson $95.17 USD -1.05
Medtronic PLC $73.56 USD +0.04
Terumo Corp ¥3,340 JPY +85.00
View Industry Companies
 

Industry Analysis

NSPR

Industry Average

Valuation NSPR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.4x
Price/Book 6.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSPIREMD INC, please visit www.inspire-md.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.